Electroporation And Electrofusion Market 2024-2028
The electroporation and electrofusion market is forecasted to grow by USD 238.95 mn during 2023-2028, accelerating at a CAGR of 7.27% during the forecast period. The report on the electroporation and electrofusion market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence and prevalence of cancer, rising demand for biologics leading to increased demand for electroporation and electrofusion, and rising demand for monoclonal antibodies.
Technavio's electroporation and electrofusion market is segmented as below:
By Product
By End-user
- Industrial laboratories and CROs
- Academic and government research institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the high demand for biopharmaceuticals as one of the prime reasons driving the electroporation and electrofusion market growth during the next few years. Also, increasing demand for gene therapy and expanding field of regenerative medicine will lead to sizable demand in the market.
The report on the electroporation and electrofusion market covers the following areas:
- Electroporation and electrofusion market sizing
- Electroporation and electrofusion market forecast
- Electroporation and electrofusion market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroporation and electrofusion market vendors that include AngioDynamics Inc., BEATIFIC Corp., BEX Co. Ltd., Bio Rad Laboratories Inc., Biogenuix Medsystems Pvt. Ltd., Celetrix LLC, Eppendorf SE, Gamma Biosciences, Gel Co. Inc, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, MoBiTec GmbH, Nepa Gene Co. Ltd., Richmond Scientific Ltd., Thermo Fisher Scientific Inc., and Westburg BV. Also, the electroporation and electrofusion market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.